Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (107 total)
-
Autor: CDC
Tema: Training and Exercises
Tipo de elemento: Exercise
Fecha de actualización: 2020-06-26
Descripción: Training materials on: Clinical Care & Infection Control, Personal Protective Equipment (PPE), Nonpharmaceutical Interventions (NPIs), Emergency Preparedness and Response, and Additional Topics. -
Autor: Geleris, Joshua, Yifei Sun, Jonathan Platt, Jason Zucker, Matthew Baldwin, George Hripcsak, Angelena Labella, Daniel K. Manson, Christine Kubin, R. Graham Barr, Magdalena E. Sobieszczyk, and Neil W. Schluger.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-06-18
Descripción: Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. -
Autor: Iversen, Patrick L., Christopher D. Kane, Xiankun Zeng, Rekha G. Panchal, Travis K. Warren, Sheli R. Radoshitzky, Jens H. Kuhn, Rajini R. Mudhasani, Christopher L. Cooper, Amy C. Shurtleff, Farooq Nasar, Melek M. E. Sunay, Allen J. Duplantier, Brett…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-06-18
Descripción: The PALM trial in the Democratic Republic of the Congo identified a statistically significant survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute Ebola virus disease; however, substantial gaps remain in improving… -
Autor: Tedder, Richard S., and Malcolm G. Semple.
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2020-06-15
Descripción: We read with considerable interest the Comment from Long Chen and colleagues about the potential use of convalescent plasma for the treatment of COVID-19. -
Autor: Meng, Xianmin, Yun Ling, Li Zhang, Qian Zhang, Ping Dong, Tongyu Zhu, and Hongzhou Lu.
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2020-06-11
Descripción: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become a serious public health threat to the whole world, and the number of infected is still rising dramatically at this moment. Several studies have confirmed that cytokine…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: the ACTT-1 Study Group Members
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2020-05-22
Descripción: Discussing "a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 with evidence of lower respiratory tract involvement." -
Autor: National Institute of Allergy and Infectious Diseases (NIAID)
Tema: Research
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-05-07
Descripción: This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in… -
Autor: Wright, David J. M.
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2020-05-07
Descripción: The Comment by Marc Feldman and colleagues,1 published recently in The Lancet, discussed the potential of anti-tumor necrosis factor (TNF) therapy to inhibit development of a cytokine storm in patients with coronavirus disease 2019 (COVID-19).… -
Autor: Bénézit, François, Paul Le Turnier, Charles Declerck, Cécile Paillé, Matthieu Revest, Vincent Dubée, Pierre Tattevin, Cédric Arvieux, Marion Baldeyrou, Jean-Marc Chapplain, Pauline Comacle, Solène Patrat-Delon, Anne Maillard, Mélanie Poinot,…
Tema: Intake and Internal Transport
Tipo de elemento: Publicación
Fecha de actualización: 2020-04-15
Descripción: Early and accurate diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is key to the management of the coronavirus disease 2019 (COVID-19) pandemic. -
Autor: Grein, Jonathan, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L. Green, François-Xavier Lescure, Emanuele Nicastri, Rentaro Oda, Kikuo Yo, Eugenia Quiros-Roldan, Alex Studemeister,…
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2020-04-10
Descripción: Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2.